ENDOTHELIAL CELL RESPONSES TO SHOCK AND TRAUMA
ENDOTHELIAL CELL RESPONSES TO SHOCK AND TRAUMA
批准号:
2593086
负责人:
JOHN Marshall HARLAN
金额:
$26.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-05-01 至 2001-04-30
关键词:
BCL2 gene /protein apoptosis biological signal transduction calpain enzyme activity gene expression gene induction /repression hemorrhagic shock hypoxia interleukin 8 nuclear factor kappa beta protease inhibitor protein structure function protein tyrosine kinase reperfusion respiratory oxygenation shock thymus tissue /cell culture transcription factor transfection trauma tumor suppressor proteins vascular endothelium
中文摘要
缺血性(缺氧性)细胞损伤是各种组织损伤的基础
临床疾病。越来越多的证据表明,
组织损伤发生在缺血组织的复氧(再灌注)之后。
缺血后的细胞死亡可能与固有细胞的激活有关
[自杀]程序导致细胞凋亡。可能导致再灌注损伤
由信号触发的炎症级联反应的激活
因缺血或再灌流而产生,导致细胞凋亡。
了解细胞活化/凋亡的分子基础
缺氧/复氧损伤可能提示新的治疗方法
与之相关的重大临床疾病。申请人假定
有几个信号通路参与内皮细胞。
S对缺氧/复氧的反应。申请人假设
应激激活蛋白激酶和p38激酶(SAPK/p38)通路
参与了促炎反应的激活,并且,沿着
与P53蛋白共同促进细胞凋亡。相反,核因子-kB途径是
是诱导细胞保护通路所必需的
既有促凋亡作用,也有促炎作用。申请人建议
SAPK/p38通路或P53蛋白可能是一个有吸引力的靶点
低氧/复氧诱导的损伤,其中抑制核因子-kB
单独的信号通路可能通过以下方式影响内皮细胞的存活
防止细胞保护蛋白的诱导。总目标
这一应用的目的是阐明促进
存活率和那些激活促炎或促凋亡的细胞
内皮细胞在缺氧/复氧过程中的反应。这个
这项建议的具体目的是:1.确定表达
和调控内皮细胞中的细胞保护蛋白
低氧/复氧;2.确定核因子-kB在血管内皮细胞损伤中的作用。
内皮细胞中促炎基因和细胞保护基因的诱导
细胞在缺氧/复氧中的作用;3.确定SAPK/p35的作用
促炎症和促凋亡反应中的激酶途径
内皮细胞缺氧/复氧;4.测定血管内皮细胞
血管内皮细胞白介素8基因表达的调控机制
细胞在缺氧/复氧过程中的作用;以及5.确定
P53蛋白在缺氧诱导内皮细胞凋亡中的作用
英文摘要
Ischemic (hypoxic) cell injury underlies tissue damage in diverse
clinical disorders. Increasing evidence indicates that additional
tissue damage follows reoxygenation (reperfusion) of ischemic tissue.
Cell death following ischemia may involve activation of a intrinsic cell
[suicide] program leading to apoptosis. Reperfusion injury may result
from activation of an inflammatory cascade, triggered by signals
generated by ischemia or following reperfusion, leading to apoptosis.
Understanding the molecular basis of cellular activation/apoptosis in
hypoxia/reoxygenation injury may suggest new approaches to therapy of
the associated major clinical disorders. The applicant postulates that
there are several signaling pathways involved in the endothelial cell
s response to hypoxia/reoxygenation. The applicant hypothesizes that
the stress-activated protein kinase and p38 kinase (SAPK/p38) pathways
are involved in the activation of pro-inflammatory responses, and, along
with p53 protein promote apoptosis. In contrast, the NF-kB pathway is
required for the induction of cytoprotective pathways that is anti-
apoptotic as well as pro-inflammatory. The applicant suggests that the
SAPK/p38 pathways or the p53 protein may be an attractive target for
hypoxia/reoxygenation induced injury, where as inhibition of the NF-kB
signaling pathway alone may compromise endothelial cell survival by
preventing the induction of cytoprotective proteins. The overall goal
of this application is to elucidate the pathways and genes that promote
survival and those that activate pro-inflammatory or pro-apoptotic
responses in endothelial cells during hypoxia/reoxygenation. The
specific aims in this proposal are thus: 1. to determine the expression
and regulation of cytoprotective proteins in endothelial cells during
hypoxia/reoxygenation; 2. to determine the role of NF-kB in the
induction of pro-inflammatory and cytoprotective genes in endothelial
cells during hypoxia/reoxygenation; 3. to define the role of SAPK/p35
kinase pathways in pro-inflammatory and pro-apoptotic responses to
endothelial cells in hypoxia/reoxygenation; 4. to determine the
mechanisms that regulate interleukin-8 gene expression in endothelial
cells during hypoxia/reoxygenation; and 5. to determine the role of the
p53 protein in hypoxia induced endothelial cell apoptosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Endothelial Toll-Like Receptor-4 Signaling in Sepsis
-
批准号:7031621
-
项目类别:
-
资助金额:$22.21万
-
财政年份:2005
-
负责人:JOHN Marshall HARLAN
-
依托单位:
Endothelial Toll-Like Receptor-4 Signaling in Sepsis
-
批准号:7418682
-
项目类别:
-
资助金额:$21.56万
-
财政年份:2005
-
负责人:JOHN Marshall HARLAN
-
依托单位:
Macrophage Apoptosis in Atherogenesis
-
批准号:6905206
-
项目类别:
-
资助金额:$37.9万
-
财政年份:2005
-
负责人:JOHN Marshall HARLAN
-
依托单位:
Macrophage Apoptosis in Atherogenesis
-
批准号:7039213
-
项目类别:
-
资助金额:$37.01万
-
财政年份:2005
-
负责人:JOHN Marshall HARLAN
-
依托单位:
Administration
-
批准号:7140042
-
项目类别:
-
资助金额:$11.0万
-
财政年份:2005
-
负责人:JOHN Marshall HARLAN
-
依托单位:
Macrophage Apoptosis in Atherogenesis
-
批准号:7224193
-
项目类别:
-
资助金额:$35.94万
-
财政年份:2005
-
负责人:JOHN Marshall HARLAN
-
依托单位:
Macrophage Apoptosis in Atherogenesis
-
批准号:7391727
-
项目类别:
-
资助金额:$35.94万
-
财政年份:2005
-
负责人:JOHN Marshall HARLAN
-
依托单位:
Endothelial Toll-Like Receptor-4 Signaling in Sepsis
-
批准号:6923080
-
项目类别:
-
资助金额:$22.74万
-
财政年份:2005
-
负责人:JOHN Marshall HARLAN
-
依托单位:
VLA-4 and VCAM-1 in Advanced Atherosclerosis
-
批准号:7140037
-
项目类别:
-
资助金额:$24.84万
-
财政年份:2005
-
负责人:JOHN Marshall HARLAN
-
依托单位:
VLA-4 And VCAM-1 in Advanced Atherosclerosis
-
批准号:6858453
-
项目类别:
-
资助金额:$37.9万
-
财政年份:2005
-
负责人:JOHN Marshall HARLAN
-
依托单位:
Endothelial Toll-Like Receptor-4 Signaling in Sepsis
-
批准号:7226200
-
项目类别:
-
资助金额:$21.56万
-
财政年份:2005
-
负责人:JOHN Marshall HARLAN
-
依托单位:
BLOOD CELL/ENDOTHELIAL ADHESIVE INTERACTIONS
-
批准号:6654168
-
项目类别:
-
资助金额:$26.64万
-
财政年份:2002
-
负责人:JOHN Marshall HARLAN
-
依托单位:
ENDOTHELIAL CELL APOPTOSIS
-
批准号:6575712
-
项目类别:
-
资助金额:$6.54万
-
财政年份:2002
-
负责人:JOHN Marshall HARLAN
-
依托单位:
Endothelial Cell Activation and Apoptosis in Atherogenesis
-
批准号:6678758
-
项目类别:
-
资助金额:$40.52万
-
财政年份:2002
-
负责人:JOHN Marshall HARLAN
-
依托单位:
NEUTROPHIL APOPTOSIS IN ACUTE LUNG INJURY
-
批准号:6564873
-
项目类别:
-
资助金额:$28.24万
-
财政年份:2001
-
负责人:JOHN Marshall HARLAN
-
依托单位:
BLOOD CELL/ENDOTHELIAL ADHESIVE INTERACTIONS
-
批准号:6488258
-
项目类别:
-
资助金额:$26.64万
-
财政年份:2001
-
负责人:JOHN Marshall HARLAN
-
依托单位:
ENDOTHELIAL CELL APOPTOSIS
-
批准号:6302085
-
项目类别:
-
资助金额:$17.71万
-
财政年份:2000
-
负责人:JOHN Marshall HARLAN
-
依托单位:
BLOOD CELL/ENDOTHELIAL ADHESIVE INTERACTIONS
-
批准号:6353049
-
项目类别:
-
资助金额:$26.64万
-
财政年份:2000
-
负责人:JOHN Marshall HARLAN
-
依托单位:
REGULATION OF LEUKOCYTE AND VESSEL WALL CELL ADHESION
-
批准号:6202176
-
项目类别:
-
资助金额:$25.32万
-
财政年份:1999
-
负责人:JOHN Marshall HARLAN
-
依托单位:
ENDOTHELIAL CELL APOPTOSIS
-
批准号:6109240
-
项目类别:
-
资助金额:$17.71万
-
财政年份:1999
-
负责人:JOHN Marshall HARLAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: